Personalis, Inc. Financing Cash Flow
Personalis, Inc. (PSNL) reported Financing Cash Flow of $25.82 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-04
- Personalis, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $7.99M.
- Personalis, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $17.83M, a 11.24% decline year-over-year.
- Personalis, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $110.89M, a 123.57% increase year-over-year.
- Personalis, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$317.00K, a 100.51% decline year-over-year.
- Personalis, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $130.34M, a 13.66% increase from fiscal 2024.
- Personalis, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $114.67M, a 939.54% increase from fiscal 2023.
- Personalis, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $11.03M, a 707.54% increase from fiscal 2022.
- Personalis, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $1.37M, a 99.20% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $25.82M 10-Q · filed 2026-08-04 | $136.71M derived: sum of 3 quarters · filed 2026-08-04 | $136.40M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $17.83M 10-Q · filed 2026-05-07 | $128.72M derived: sum of 2 quarters · filed 2026-05-07 | $128.41M derived: sum of 3 quarters · filed 2026-05-07 | $128.08M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $110.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $110.58M derived: sum of 2 quarters · filed 2026-02-26 | $110.25M derived: sum of 3 quarters · filed 2026-08-04 | $130.34M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$317.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$644.00K derived: sum of 2 quarters · filed 2026-08-04 | $19.44M 10-Q · filed 2025-11-04 | $69.04M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$327.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $19.76M 10-Q · filed 2026-08-04 | $69.36M derived: sum of 3 quarters · filed 2026-08-04 | $131.79M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $20.09M 10-Q · filed 2026-05-07 | $69.69M derived: sum of 2 quarters · filed 2026-05-07 | $132.11M derived: sum of 3 quarters · filed 2026-05-07 | $133.63M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $49.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $112.03M derived: sum of 2 quarters · filed 2026-02-26 | $113.54M derived: sum of 3 quarters · filed 2026-02-26 | $114.67M 10-K · filed 2026-02-26 |
| 2024-09-30 | $62.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $63.94M derived: sum of 2 quarters · filed 2025-11-04 | $65.07M 10-Q · filed 2025-11-04 | $74.89M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $2.65M 10-Q · filed 2025-08-05 | $12.46M derived: sum of 3 quarters · filed 2025-08-05 | $12.75M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $1.13M 10-Q · filed 2025-05-06 | $10.95M derived: sum of 2 quarters · filed 2025-05-06 | $11.23M derived: sum of 3 quarters · filed 2025-05-06 | |
| 2023-12-31 | $9.82M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $10.11M derived: sum of 2 quarters · filed 2025-02-27 | $11.03M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $290.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $1.22M 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | $925.00K 10-Q · filed 2024-08-07 | |||
| 2022-12-31 | $511.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.27M derived: sum of 2 quarters · filed 2024-02-28 | $851.00K derived: sum of 3 quarters · filed 2024-02-28 | $1.37M 10-K · filed 2024-02-28 |
| 2022-09-30 | $760.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $340.00K derived: sum of 2 quarters · filed 2023-11-07 | $855.00K 10-Q · filed 2023-11-07 | $2.20M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$420.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $95.00K 10-Q · filed 2023-08-08 | $1.44M derived: sum of 3 quarters · filed 2024-02-28 | $936.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $515.00K 10-Q · filed 2023-05-03 | $1.86M derived: sum of 2 quarters · filed 2024-02-28 | $1.36M derived: sum of 3 quarters · filed 2024-02-28 | $7.37M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $841.00K derived: sum of 2 quarters · filed 2024-02-28 | $6.85M derived: sum of 3 quarters · filed 2024-02-28 | $169.70M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$506.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $5.50M derived: sum of 2 quarters · filed 2022-11-02 | $168.35M 10-Q · filed 2022-11-02 | $169.29M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $6.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $168.86M 10-Q · filed 2022-08-03 | $169.80M derived: sum of 3 quarters · filed 2023-02-23 | $288.48M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $162.85M 10-Q · filed 2022-05-04 | $163.79M derived: sum of 2 quarters · filed 2023-02-23 | $282.47M derived: sum of 3 quarters · filed 2023-02-23 | $283.79M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $941.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $119.62M derived: sum of 2 quarters · filed 2023-02-23 | $120.94M derived: sum of 3 quarters · filed 2023-02-23 | $121.27M 10-K · filed 2023-02-23 |
| 2020-09-30 | $118.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $120.00M derived: sum of 2 quarters · filed 2021-11-04 | $120.33M 10-Q · filed 2021-11-04 | $120.80M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $1.64M 10-Q · filed 2021-08-04 | $2.12M derived: sum of 3 quarters · filed 2022-02-24 | -$20.57M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $323.00K 10-Q · filed 2021-05-05 | $794.00K derived: sum of 2 quarters · filed 2022-02-24 | -$21.89M derived: sum of 3 quarters · filed 2022-02-24 | $120.89M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $471.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$22.21M derived: sum of 2 quarters · filed 2022-02-24 | $120.56M derived: sum of 3 quarters · filed 2022-02-24 | $134.95M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$22.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $120.09M derived: sum of 2 quarters · filed 2020-11-05 | $134.48M 10-Q · filed 2020-11-05 | $134.51M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $142.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $157.16M 10-Q · filed 2020-08-06 | $157.20M derived: sum of 3 quarters · filed 2021-02-25 | $156.97M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $14.39M 10-Q · filed 2020-05-07 | $14.42M derived: sum of 2 quarters · filed 2021-02-25 | $14.20M derived: sum of 3 quarters · filed 2021-02-25 | |
| 2018-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$188.00K derived: sum of 2 quarters · filed 2021-02-25 | -$591.00K 10-K · filed 2021-02-25 | |
| 2018-09-30 | -$226.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$629.00K 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | -$403.00K 10-Q · filed 2019-08-13 | |||
| 2017-12-31 | $16.40M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |